ASCO Daily News
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ASCO Daily News
May 2, 2024, 14:30 |
Societies
Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC - ASCO
American Society of Clinical Oncology (ASCO) shared on X: “Breaking news from the ASCO Plenary Series:…
Apr 27, 2024, 11:23 |
Insight
APCCC24 Highlights: Lutetium-177 PSMA RLT Toxicity Management by Neeraj Agarwal
Neeraj Agarwal shared on X/Twitter: "How to monitor and manage toxicities with Lutetium-177 PSMA RLT? Luis…
Apr 6, 2024, 14:49 |
Insight
Chul Kim: Check out our article featured in ASCO Daily News
Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, recently shared…
Jan 29, 2024, 13:54 |
Blog
Yousef Zakharia: The Right Person in the Appropriate Position as Editor in Chief for ASCO DailyNews
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post by…
Jan 13, 2024, 12:21 |
Blog
Maite Bourlon: Adjuvant pembrolizumab is SOC for high-risk resected RCC
Maite Bourlon, the Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas…
Dec 29, 2023, 05:18 |
Blog
U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on their X/Twitter page: ''Breaking from Journal of…
May 18, 2023, 13:57 |
Insight
Learn how to better meet the needs of older patients with cancer during ASCO23
Given increased life expectancy and the rapid pace at which the population of older adults…
All:
7
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube